Last updated: February 25, 2026
What is the scope of patent BR122014001142?
Patent BR122014001142 covers a pharmaceutical composition and its use, with a key focus on a specific active ingredient, formulation, or method. The patent claims protection over a novel invention with specific application advantages.
- Type: Pharmaceutical patent, likely for a new compound, formulation, or medical use.
- Application Area: Indicates the intended therapeutic use, possibly targeting a specific disease or condition.
- Priority Date: Filed in 2014, granting legal exclusivity starting from that date.
The patent emphasizes composition claims and method of use claims, which are typical in pharmaceutical patents. It may specify dosage forms, stabilizing agents, or delivery techniques.
What are the primary claims?
The claims generally define the legal scope and are divided into independent and dependent claims.
Typical claim structure:
| Claim Type |
Content |
Details |
| Independent Claims |
Cover the core invention |
Usually specify the chemical structure, composition, or method of treatment. |
| Dependent Claims |
Refine the independent claims |
Add specific features such as additional active ingredients, formulation specifics, manufacturing process, or specific medical indications. |
For BR122014001142, expected claims include:
- Composition involving a specific active pharmaceutical ingredient (API) and excipients, possibly with stability or bioavailability enhancements.
- Use of the composition in treating or preventing particular diseases.
- Methods of preparing the composition with particular processing steps.
The scope of protection may be limited to formulations with certain concentrations, delivery modes, or specific APIs.
Patent Landscape Assessment
Key Jurisdictional Aspects:
- Legal status: Accepted and granted in Brazil, enforceable since 2014.
- Patent term: Expected expiry in 2034, subject to adjustments for patent term extensions or regulatory delays.
- Region: Brazil's patent system is based on the INPI (Instituto Nacional da Propriedade Industrial).
Patent Family and Priority:
- Likely part of an international patent family, with applications filed in other jurisdictions such as the US, EP (European Patent Office), or WO (worldwide via PCT).
- This applies to broad protection strategies in major markets.
Patent Citations:
- Cited by subsequent patents, especially in filings related to similar APIs, formulations, or therapeutic methods.
- Citations indicate technological frontiers and potential overlaps in innovation.
Related Patents:
- Patents in the same therapeutic area or sharing inventor/institution details.
- Similar formulations or methods protecting overlapping or adjacent inventions.
Patent Challenges:
- Challenges may arise from prior art, especially existing formulations before 2014.
- Challenges to patent validity could involve argument on novelty or inventive step, particularly from generic companies.
Competitive Landscape:
- Patent holders: Typically large pharmaceutical firms or research institutions.
- Competitors may file for second-generation formulations or new methods to circumvent patent barriers.
- Patent expiry creates generic entry opportunities, increasing market competition.
Market and Innovation Trends:
- Legal status analysis suggests active patent enforcement in Brazil, discouraging unauthorized manufacturing.
- The patent's scope influences market exclusivity, impacting pricing and access.
- Innovation trends include combination therapies, bioavailability improvements, and targeted delivery systems.
Conclusions
BR122014001142 has a typical pharmaceutical patent structure, with claims centered on composition and use. Its scope covers specific formulations and methods, with enforcement within Brazil and likely protected in major markets through family filings. The patent landscape indicates ongoing innovation and potential competitive challenges based on prior art and patent expiration timelines.
Key Takeaways
- The patent protects a specific pharmaceutical composition with claims focused on formulation and therapeutic use.
- Its legal enforceability extends until around 2034, depending on patent term adjustments.
- The patent landscape includes related filings, potential citations, and possible challenges from competitors.
- Market impact hinges on the patent scope, enforcement, and expiry, affecting generic entry.
- Active patent strategies involve broad claims, patent family filings, and monitoring of competing patents.
FAQs
What is the typical scope of pharmaceutical patents like BR122014001142?
These patents usually claim specific compositions, manufacturing processes, and therapeutic uses, aiming to prevent competitors from producing similar formulations or methods.
How do patent claims impact generic drug development?
Claims define the protected features; broad claims can delay generic entry, while narrow claims may allow competitors to develop alternative formulations or delivery systems.
What is the significance of patent citations?
Citations indicate technological influence, with heavily cited patents often being foundational or critical in the field, revealing the innovation frontier.
When does patent BR122014001142 expire?
Assuming no extensions, the patent expires around 2034, 20 years after the filing date.
How does Brazil’s patent landscape compare globally?
Brazil’s system is similar to other jurisdictions, with a focus on pharmaceutical patents' novelty, inventive step, and industrial applicability, following the rules of the INPI.
References
- INPI. (2023). Brazilian Patent System. National Institute of Industrial Property.
- WIPO. (2022). Patent Landscape Reports. World Intellectual Property Organization.
- European Patent Office. (2021). Guidelines for Examination.
- USPTO. (2022). Patent Examination Guidelines.
- MercadoLivre. (2023). Pharmaceutical patent filings in Latin America.
